BTK inhibitors vs BCL2 inhibitors in untreated CLL_Susan O'Brien, MD; #DDHO2021
2:30
Chronic Lymphocytic Leukemia
BTK inhibitors vs BCL2 inhibitors in untreated CLL_Susan O'Brien, MD; #DDHO2021
Chronic Lymphocytic Leukemia Similar Videos
Similar Videos
-
Practical issues in CLL care: oral adherence, MRD testing, and managing treatment-related adverse events_Nicole Lamanna, MD; #BeyondASCO
12:51
-
Module 3: Zanubrutinib for Hematologic Malignancies_Matthew Davids, MD, MMSc_Catherine Coombs, Anthony Mato, MD, MSCE
7:59
-
Recently presented data and optimal therapeutic approaches in relapsed/refractory CLL_Jennifer Brown, MD, PhD; #BeyondASCO
13:52
